Clinical Study

Lisdexamfetamine In Binge Eating Disorder (Bed): Fmri Effects

Posted Date: May 9, 2017

  • Investigator: Susan Lynn Mcelroy
  • Co-Investigator: Anna Guerdjikova
  • Specialties:
  • Type of Study: Drug

The purpose of this research study is to gather information about the effects of Lisdexamfetamine treatment on brain function in Binge Eating Disorder (BED) patients undergoing 12 weeks of open-label treatment. To do so, we will use magnetic resonance ima

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Are A Woman, 18 To 55 Years Of Age, Inclusive, You Have Been Diagnosed With Bed, And You Are Currently Seeking Treatment For Bed At Lindner Center Of Hope. Bed Is The Most Common Eating D

Keywords:

Approved Medication For Binge Eating, Binge, Binge Eating, Lisdexamfetamine, Vyvanse

For More Information:

Anna
Guerdjikova
anna.guerdjikova@lindnercenter.org

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Direct Oral Anticoagulants May Help Some AF Patients

    UC researchers have tested a computerized decision analytic model to determinethe benefit direct oral anticoagulants has for patients with atrialfibrillation.